Differences in overall survival of penile cancer patients versus population-based controls.
Lukas ScheipnerStefano TapperoMattia Luca PiccinelliFrancesco BarlettaCristina Cano GarciaReha-Baris IncesuSimone MorraZhe TianFred SaadShahrokh F ShariatCarlo TerroneOttavio De CobelliAlberto BrigantiFelix K H ChunDerya TilkiNicola LongoMaximilian SelesSascha AhyaiPierre I KarakiewiczPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)
SCCP patients exhibit worse OS across all stages. The difference in OS at 5 years between SCCP and age-matched male population-based controls ranged from 17% to 61%. At 5 years, CSM accounted for 12% to 60% of all deaths, across all stages.